View the research
We’ve worked with a team of independent clinicians and specialists to ensure our products are effective and safe for clinical use.
In a trial by Kaiser Permanente Fontana Medical Center results revealed 67% of patients did not require additional antiemetics after administering QueaseEASE in the PACU
In an investigational trial involving 65 patients at Providence St. Patrick Hospital, the need for any additional antiemetics decreased by 71.8% when QueaseEASE was used
A study conducted in a Level 1 Trauma Center Pediatric Emergency Department showed that 79% of patients’ nausea was reduced or eliminated after using QueaseEASE®
A small trial conducted in the PACU found that 15 out of 52 of the patients did not require any additional antiemetics after receiving QueaseEASE®,
An evaluative trial done by the Sutter Health Alta Bates Summit Medical Center, revealed that QueaseEASE® helped to relieve PONV in 70% of PACU patients.
In a prospective randomized study that compared QueaseEASE® to standard post-discharge nausea care, 100% of the patients using QueaseEASE® found effective relief from their PDN.
At the St. Jude Children’s Research Hospital, data collected from a three-month pilot project showed QueaseEASE® to be a feasible and effective intervention for PONV.
The Scripps Clinic Carmel Valley conducted a small investigational trial that found that 62% of the patients got relief from their nausea after inhaling QueaseEASE®.
A Floyd Memorial Hospital study showed that using QueaseEASE® for post-discharge nausea reduced nausea 100% of the time. In addition, nearly half experienced complete relief.
In a study conducted by Madigan Healthcare System, QueaseEASE® users showed a statistically significant decrease in nausea, and a significantly higher perception of treatment effectiveness.
In a randomized study by UMass Lowell School of Nursing comparing QueaseEASE® to conventional medication, PONV relief was achieved within 7.8 minutes for QueaseEASE® users,
In a descriptive, qualitative study by the University of Colorado comparing QueaseEASE® to alcohol pads, patients and nurses both reported significantly higher satisfaction with QueaseEASE®.
In a study conducted by Houston Methodist Sugar Land Hospital, results showed a 60% reduction in antiemetic drug use after patients inhaled QueaseEASE® in the PACU.
Oregon Health and Science University conducted a limited size clinical trial of QueaseEASE® testing efficacy and satisfaction. Findings showed 85% of users had total relief
A study conducted at Stephens Memorial Hospital showed that 90% of patients using QueaseEASE® experienced some relief from their nausea, with 50% experiencing complete relief.
A Queens Medical Center trial found a 15-minute decrease in PACU stay when nauseated patients used QueaseEASE®, as well as a 37% decrease in Phenergan use
Clinical trials by Bon Secour St. Francis Health System concluded that 70% of patients reported nausea relief after using QueaseEASE®, both in PACU and post-discharge.
“QueaseEASE is my first line of defense when my patient says they feel nauseated.”
Pam Chandler
RN Ambulatory Surgical Unit
Trusted and used in over 2,000 healthcare systems, including:
Multiple independent health systems have conducted their own research into the effectiveness of QueaseEASE.
Their insights suggest that QueaseEASE ® provides a statistically significant decrease in queasiness, compared to a placebo, as well as a significantly higher perception of care effectiveness.
(All these studies were done independently with no financial or research involvement from Soothing Scents)
We provide product samples, templates and administrative support to independent research teams wanting to explore the effectiveness of aromatherapy interventions.
Speak to us to get started.
“As a nurse, my ultimate goal is to make my patient’s experience the best it can be. That’s why I love QueaseEASE.”
Melissa Brown
RN Clinical Nurse Supervisor, Ambulatory Surgical Unit
